Form 4: NeueHealth CFO Jay Matushak Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


NeueHealth's Chief Financial Officer, Jay Matushak, sold 472 shares of common stock on May 12, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

  • On May 12, 2025, Jay Matushak, the Chief Financial Officer of NeueHealth, Inc., sold 472 shares of the company's common stock.
  • The sale was executed at a weighted average price of $6.76 per share, with individual transactions ranging from $6.67 to $6.83.
  • This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
  • Following the transaction, Matushak directly owns 40,556 shares of NeueHealth common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (covering tax obligations) and doesn't inherently indicate positive or negative sentiment regarding the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it involves a small number of shares sold by an executive to cover tax obligations.

Key Dates

DateDescription
05/12/2025Date of the stock sale transaction.
05/14/2025Date of signature for the Form 4 filing.

Keywords

NeueHealth, Jay Matushak, CFO, stock sale, Form 4, insider trading, tax obligations, restricted stock units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.